Cancer clinical trials in the region Île-de-France

787 currently recruiting clinical trials
Region Île-de-France
Phase 1 / Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT04104776 #2023-508002-20-00
Required histologic sub types
Urothelial carcinoma
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
ARID1A
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2 Endometrial cancer #NCT04104776 #2023-508002-20-00
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
ARID1A
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2 Lung cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT04104776 #2023-508002-20-00
Required histologic types
Mesothelium Primary peritoneal cancer (PPC)
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
Other mutation
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2 Lymphoma #NCT04104776 #2023-508002-20-00
Required histologic types
B cell lymphoma T cell lymphoma
Required histologic sub types
Large B cell lymphoma Peripheral T cell lymphoma
Required central nervous system lesions
None Treated / Controled
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive Allogeneic stem cell transplant
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2 Endometrial cancer #NCT04104776 #2023-508002-20-00
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Excluded genetic anomalies
ARID1A
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2 Ovarian / Fallopian tubes / Peritoneum cancer #NCT04104776 #2023-508002-20-00
Required histologic types
Epithelial ovarian cancer
Required histologic sub types
Clear cell carcinoma
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
ARID1A
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy Targeted therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2 Prostate cancer #NCT04104776 #2023-508002-20-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Novartis Pharmaceuticals
Phase 1 / Phase 2 Lymphoma #NCT06090539
Required histologic types
B cell lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
7 recruiting sites
Bristol-Myers Squibb
Phase 1 / Phase 2 Brain tumors / Central nervous system tumors #NCT06622434 #2024-514567-26-00
Required histologic types
Gliomas
Required histologic sub types
Glioblastoma
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded previous treatments
Immunotherapy Chemotherapy Radiotherapy Bevacizumab
2 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer Small intestine and appendix cancer #NCT06439888
Required disease stage
Metastatic Metastatic Castration-resistant
1 recruiting site
Gustave Roussy, Campus du cancer, Grand Paris